BREXLIEVA 200 MG
Celecoxib Mouth Dissolving Tablets 200 mg
BREXLIEVA 200 MG (Celecoxib Mouth Dissolving Tablets 200 mg) is a prescription medication containing Celecoxib 200 mg, a non-steroidal anti-inflammatory drug (NSAID) belonging to the Selective COX-2 Inhibitor class. It is formulated as a mouth dissolving tablet (MDT), allowing convenient administration without the need for swallowing conventional tablets. Celecoxib works by selectively inhibiting the Cyclooxygenase-2 (COX-2) enzyme, which plays a key role in the production of prostaglandins responsible for pain, inflammation, and swelling. By reducing prostaglandin production, Celecoxib helps relieve pain and inflammation while having a lower risk of stomach irritation compared to some traditional NSAIDs. BREXLIEVA 200 MG is commonly prescribed for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute pain, musculoskeletal disorders, and inflammatory conditions. It may also be used as part of supportive care in selected clinical situations under medical supervision. The mouth dissolving formulation offers ease of administration, especially for patients who experience difficulty swallowing conventional tablets. BREXLIEVA 200 MG is commonly used for: Osteoarthritis Rheumatoid Arthritis Ankylosing Spondylitis Acute Pain Management Musculoskeletal Pain Joint Pain and Inflammation Post-Operative Pain Chronic Inflammatory Conditions Manufactured according to stringent pharmaceutical quality standards, BREXLIEVA 200 MG is designed to provide consistent quality, safety, and therapeutic effectiveness. Patients using Celecoxib should follow medical advice carefully and attend routine follow-up evaluations when required.
View Details